Hand-stabilising glove team shortlisted for Science Start-up of the Year
Six things doctors would like you to know about antibiotics
Enormous ‘ghost’ galaxy spotted hiding next to the Milky Way
One of the largest teaching and research organisations in the UK, with a reputation for excellence and a vibrant and international working community.
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.
Imperial scientists have helped unravel the genetic code of tuberculosis (TB), enabling doctors to tailor treatments to each individual patient.
A new study reveals how the global burden of childhood tuberculosis could be reduced by better targeting of high-risk households
Tissues grown in the lab from stem cells may fail to live up their therapeutic promise because the cells choose their own fate.
The expert-led research groups within the Department cover five divisions
Find out more
The Department hosts undergraduate offerings - like the MBBS - as well as a variety of MSc and MRes options.
Find out more
Our research has directly led to far-reaching impacts and benefits being realised on a global scale.
Imperial mourns the passing of Professor James Stirling
12 November 2018
Annual amnesty to tackle antibiotic resistance
07 November 2018
12 November 2018, 12:00 – 14:00
Antibiotic Amnesty @ South Kensington Campus